Simona Bindi

USPTO Granted Patents = 14 (Patent Applications = 1)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 12(Granted Patents)

Location History:

Florence, IT (2009 - 2012)
Milan, IT (2009 - 2023)

Company Filing History:

10 out of 138

Nerviano Medical Sciences S.r.l.

1 out of 832,718

Other

patents

Years Active: 2009-2023

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11833153 - N-(substituted-phenyl)-sulfonamide derivatives as kinase inhibitors (2023-12-05),

2. 11491158 - N-(substituted-phenyl)-sulfonamide derivatives as kinase inhibitors (2022-11-08),

3. 10918642 - N-(substituted-phenyl)-sulfonamide derivatives as kinase inhibitors (2021-02-16),

4. 10561660 - N-(substituted-phenyl)-sulfonamide derivatives as kinase inhibitors (2020-02-18),

5. 10479779 - Substituted pyrroles active as kinases inhibitors (2019-11-19),

6. 10479778 - Substituted pyrroles active as kinases inhibitors (2019-11-19),

7. 10071986 - Substituted pyrroles active as kinases inhibitors (2018-09-11),

8. 9688661 - Substituted pyrroles active as kinases inhibitors (2017-06-27),

9. 8481584 - 1H-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors (2013-07-09),

10. 8138217 - 1H-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors (2012-03-20),

11. 8017643 - Condensed heterocyclic pyrazole derivatives as kinase inhibitors (2011-09-13),

12. 7786048 - Condensed heterocyclic pyrazole derivatives as kinase inhibitors (2010-08-31),

13. 7541378 - Condensed heterocyclic pyrazole derivatives as kinase inhibitors (2009-06-02),

14. 7485661 - Heterobicyclic pyrazole derivatives as kinase inhibitors (2009-02-03),

Title: The Innovative Genius of Simona Bindi in Milan

Introduction

Simona Bindi is a prominent inventor based in Milan, Italy, renowned for her groundbreaking contributions to the field of biomedical research and drug development. With an impressive portfolio of 14 patents, she has established herself as a leading figure in the scientific community, particularly in the realm of kinase inhibitors.

Latest Patents

Among her latest innovations, Simona Bindi has developed N-(substituted-phenyl)-sulfonamide derivatives that serve as effective kinase inhibitors. These novel compounds have significant implications for treating various cell proliferative disorders, including cancer and conditions related to activated unfolded protein response pathways, such as Alzheimer's disease. Additionally, her inventions include methods for synthesizing these compounds as well as pharmaceutical compositions that incorporate them, providing valuable resources for medical treatment and research.

Career Highlights

Simona has collaborated with several prestigious organizations throughout her career. Notable among them are Nerviano Medical Sciences S.r.l. and Pfizer Italia S.r.l., where she has contributed her expertise in drug discovery and development. Her work not only showcases her inventive spirit but also emphasizes her commitment to advancing healthcare solutions.

Collaborations

In her professional journey, Simona Bindi has worked alongside talented colleagues, including Daniele Fancelli and Mario Varasi. These collaborations have played a vital role in fostering innovation and driving research efforts toward creating impactful therapeutic solutions.

Conclusion

Simona Bindi's contributions to the field of biomedical research through her patents and collaborations exemplify the essence of innovation and dedication to improving human health. As she continues to push the boundaries of scientific inquiry, her work stands as a testament to the transformative power of innovation in addressing complex medical challenges.

This text is generated by artificial intelligence and may not be accurate.